News

The U.S. Food and Drug Administration have approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to T. cruzi, which causes Chagas disease, a serious and potentially fatal parasitic infection.

Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, has announced the launching of a new e-commerce website for its Human Ultrapure Transferrin.

Geron Corporation has announced that they will be focusing on first-in-class oncology programs. As a consequence, the Company will discontinue further development of its stem cell programs and is seeking partners for these novel assets.

InteRNA Technologies B.V., a drug discovery and development company engaged in the development of microRNA-based therapeutics for oncology, has announced the establishment of its Supervisory Board.

The ability to bring biologists into the data analysis phase will be key to achieving this important goal.

Advocacy groups pushing to end research in U.S.

Majority of Patients Report Restoration of Useful Vision in Daily Life

Three industry partners to discuss global scientific trends.

In this study researchers have shown that the formation of the lipidic phases and the incorporation of the membrane protein into such materials can be separated experimentally.

Company Secures Long-term Control of Rapid IHC® Technologies